CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Patel Kinnari See Remarks | Sale | −1,330 | $21.38 | $28K | 213,993 |
| 2023-05-17 | Shah Gaurav CEO | Sale | −4,122 | $21.38 | $88K | 521,642 |
| 2023-05-17 | Militello John See Remarks | Sale | −245 | $21.38 | $5K | 6,116 |
| 2023-05-14 | Shah Gaurav CEO | Option exercise | +7,979 | 525,764 | ||
| 2023-05-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −7,979 | 55,856 | ||
| 2023-05-14 | Militello John See Remarks | Option exercise | +725 | 6,361 | ||
| 2023-05-14 | Militello John See Remarks | Option exercise · Restricted Stock Units | −725 | 5,078 | ||
| 2023-05-14 | Patel Kinnari See Remarks | Option exercise | +3,989 | 215,323 | ||
| 2023-05-14 | Patel Kinnari See Remarks | Option exercise · Restricted Stock Units | −3,989 | 27,982 | ||
| 2023-04-21 | Militello John See Remarks | Sale | −2,342 | $18.65 | $44K | 5,636 |
| 2023-04-18 | Militello John See Remarks | Option exercise | +6,364 | 7,978 | ||
| 2023-04-18 | Militello John See Remarks | Option exercise · Restricted Stock Units | +6,364 | 12,670 | ||
| 2023-04-04 | White Mark Andrew Chief Medical Officer | Grant or award | +76,662 | 76,662 | ||
| 2023-04-04 | White Mark Andrew Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +57,739 | 57,739 | ||
| 2023-02-17 | Militello John See Remarks | Sale | −1,076 | $19.06 | $21K | 1,782 |
| 2023-02-17 | Schwartz Jonathan David See Remarks | Sale | −3,557 | $19.06 | $68K | 94,546 |
| 2023-02-17 | Militello John See Remarks | Sale | −1,244 | $19.06 | $24K | 1,614 |
| 2023-02-17 | Shah Gaurav CEO | Sale | −12,194 | $19.06 | $232K | 536,885 |
| 2023-02-14 | Shah Gaurav CEO | Other acquisition | +67,785 | 737,859 | ||
| 2023-02-14 | Shah Gaurav CEO | Other disposition · Restricted Stock Units | −67,785 | 0 |
Page 16 of 19 · 374 trades